Innovative drugs for bowel and liver diseases

Our pharmaceuticals are used successfully to treat inflammatory bowel disease and cholestatic liver disease.

We focus on modern formulations and specially designed delivery systems to ensure targeted release of the active drug.

We promote knowledge in the interest of therapeutic progress

Since 1967 we have arranged internationally recognized scientific congresses, the Falk Symposia and Workshops. So far more than 200 events have been attended by some 100,000 participants from over 100 countries.

We organise and sponsor continuing medical education events - to date over 13,000 seminars have been attended by over one million physicians and patients in Germany alone.

With more than 200 publications, which are updated regularly, we provide a comprehensive literature service for healthcare professionals as well as for patients and their families.